Investing Profile

David Schenkein

VCInvestor
General Partner at GV
gv.com/team/david-schenkein/Boston, Massachusetts
Photo of David Schenkein, General Partner at GV (Google Ventures)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
GV (Google Ventures) General Partner
$250K - $50.0M
$25.0M
10
$8B
CompanyStageDateRound SizeTotal Raised
EpiBiologics
Series AJul 2023$23M
$73M
Co-investors: Alexandra Cantley (Polaris Partners), Samuel Bjork (Digitalis Ventures), Alaa Halawa
Aera Therapeutics
Series BFeb 2023$190M
Series AFeb 2023
$190M
Co-investors: Issi Rozen (GV (Google Ventures)), Josh Wolfe (Lux Capital Management), Robert Nelsen (ARCH Venture Partners)
Cerevance
Series BFeb 2023$51M
Series BApr 2020$65M
$120M
Co-investors: Jason Lettmann (Morgenthaler Ventures), Laurence Barker (SV Health Investors), Bill Gates
Leyden Labs
Series BJan 2022$140M
Series AMar 2021$47M
$190M
Co-investors: Stephen Knight (F-Prime Capital Partners), Brook Byers (Kleiner Perkins)
Prime Medicine
Series BJul 2021$200M
Series AOct 2019$120M
$320M
Co-investors: Stephen Knight (F-Prime Capital Partners), Stephen Francis (Arrive), Robert Nelsen (ARCH Venture Partners), Neil Sirni (Arrive)
Encoded Therapeutics
Series DJul 2020$140M
$240M
Co-investors: Greg Yap (Menlo Ventures)